Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth S. Shindler

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Science Translational Medicine|July 17, 2015
Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosisManzar Ashtari, Hui Zhang, Philip A Cook, et al.
Eye (London, England)|January 20, 2021
The sensitivity and specificity of retinal and choroidal folds to distinguish between mild papilloedema and pseudopapilledemaSara N Reggie, Robert A Avery, James C Bavinger, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 5, 2019
Utility of Magnetic Resonance Imaging Features for Improving the Diagnosis of Idiopathic Intracranial Hypertension Without PapilledemaRobert M Mallery, Obeidurahman F Rehmani, John H Woo, et al.
Virology|February 26, 2022
Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict β-coronaviral infection and replicationLucky Sarkar, Lauren Oko, Soham Gupta, et al.
Science Translational Medicine|February 11, 2012
AAV2 gene therapy readministration in three adults with congenital blindnessJean Bennett, Manzar Ashtari, Jennifer Wellman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2009
Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administrationFrancesca Simonelli, Albert M Maguire, Francesco Testa, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|April 27, 2018
Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other CausesAhmara G Ross, Imran Jivraj, Geoffrey Rodriguez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2025
APOSTEL-R Recommendations for Reporting Retinal Optical Coherence Tomography Studies in RodentsFrederike Cosima Oertel, Delia Cabrera Debuc, Peter A Calabresi, et al.
The New England Journal of Medicine|April 29, 2008
Safety and efficacy of gene transfer for Leber's congenital amaurosisAlbert M Maguire, Francesca Simonelli, Eric A Pierce, et al.
Lancet (London, England)|October 27, 2009
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trialAlbert M Maguire, Katherine A High, Alberto Auricchio, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Science Translational Medicine|July 17, 2015
Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosisManzar Ashtari, Hui Zhang, Philip A Cook, et al.
Eye (London, England)|January 20, 2021
The sensitivity and specificity of retinal and choroidal folds to distinguish between mild papilloedema and pseudopapilledemaSara N Reggie, Robert A Avery, James C Bavinger, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 5, 2019
Utility of Magnetic Resonance Imaging Features for Improving the Diagnosis of Idiopathic Intracranial Hypertension Without PapilledemaRobert M Mallery, Obeidurahman F Rehmani, John H Woo, et al.
Virology|February 26, 2022
Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict β-coronaviral infection and replicationLucky Sarkar, Lauren Oko, Soham Gupta, et al.
Science Translational Medicine|February 11, 2012
AAV2 gene therapy readministration in three adults with congenital blindnessJean Bennett, Manzar Ashtari, Jennifer Wellman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2009
Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administrationFrancesca Simonelli, Albert M Maguire, Francesco Testa, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|April 27, 2018
Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other CausesAhmara G Ross, Imran Jivraj, Geoffrey Rodriguez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2025
APOSTEL-R Recommendations for Reporting Retinal Optical Coherence Tomography Studies in RodentsFrederike Cosima Oertel, Delia Cabrera Debuc, Peter A Calabresi, et al.
The New England Journal of Medicine|April 29, 2008
Safety and efficacy of gene transfer for Leber's congenital amaurosisAlbert M Maguire, Francesca Simonelli, Eric A Pierce, et al.
Lancet (London, England)|October 27, 2009
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trialAlbert M Maguire, Katherine A High, Alberto Auricchio, et al.
Pageof 9